Treatment for cerebral small vessel disease: effect of relaxin on the function and structure of cerebral parenchymal arterioles during hypertension
about
Increased pressure-induced tone in rat parenchymal arterioles vs. middle cerebral arteries: role of ion channels and calcium sensitivityRelaxin activates peroxisome proliferator-activated receptor γ (PPARγ) through a pathway involving PPARγ coactivator 1α (PGC1α)Automated detection and measurement of isolated retinal arterioles by a combination of edge enhancement and cost analysisRelaxin does not improve Angiotensin II-induced target-organ damage.Astrocyte contributions to flow/pressure-evoked parenchymal arteriole vasoconstrictionRegulation of myogenic tone and structure of parenchymal arterioles by hypertension and the mineralocorticoid receptor.Increase of cortical cerebral blood flow and further cerebral microcirculatory effects of Serelaxin in a sheep model.Enhanced serelaxin signalling in co-cultures of human primary endothelial and smooth muscle cellsMicrovascular Dysfunction and Cognitive Impairment.Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatmentAcute intravenous injection of serelaxin (recombinant human relaxin-2) causes rapid and sustained bradykinin-mediated vasorelaxation.Vascular actions of relaxin: nitric oxide and beyond.Does serelaxin treatment alter passive mechanical wall properties in small resistance arteries?Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.Structural and functional brain alterations in a murine model of Angiotensin II-induced hypertension.Novel Anti-fibrotic Therapies.Short-term (48 hours) intravenous serelaxin infusion has no effect on myogenic tone or vascular remodeling in rat mesenteric arteries.Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes.The relaxin peptide family - potential future hope for neuroprotective therapy? A short review.
P2860
Q33912848-181DCA0B-3A21-4EF7-95F0-9466C65BE9D9Q34958919-9D8753C3-5496-46C4-8B21-F0FC53E00119Q35120239-D8435597-4F47-42C1-A007-547D4A414C3BQ35141812-9983342D-5844-46F5-9B15-1DE7236E252CQ35649520-29995E60-0E43-4580-8B27-001AC72189E5Q35817868-42B2C589-C831-46BC-882B-B99979E6E09BQ36073516-B193AA9B-4330-4506-BCEE-57623E3D4748Q36506903-672F97DE-C0BF-4E4B-A1BC-42CFC545FAD2Q36839870-43271938-0C67-4A05-88D7-228DD761BD4DQ37405208-D5B54FBD-80AB-4DE3-A22E-9CE378F76661Q37648577-584B58F0-8B07-4F34-902D-3AFA7BEB4196Q38945156-36B2C506-AC44-4246-8F5E-EE9420781504Q38960703-606DDDFE-2328-48BD-AC84-FEC733025339Q39116577-2029B8DC-F911-4E60-B29C-6746F55F305EQ39164134-05B34B3E-6C73-47AF-8A6C-467EB4398A96Q39377055-DFD2449E-68CA-48B7-93A8-553BE2164759Q48331109-3522F453-53DE-4FC5-BCC1-37EC44C11CAEQ55209012-38E696FD-6D5D-4780-8E89-567D604DD750Q55317785-716B15A3-0B33-455D-925B-97D000C5E34D
P2860
Treatment for cerebral small vessel disease: effect of relaxin on the function and structure of cerebral parenchymal arterioles during hypertension
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Treatment for cerebral small v ...... arterioles during hypertension
@ast
Treatment for cerebral small v ...... arterioles during hypertension
@en
type
label
Treatment for cerebral small v ...... arterioles during hypertension
@ast
Treatment for cerebral small v ...... arterioles during hypertension
@en
prefLabel
Treatment for cerebral small v ...... arterioles during hypertension
@ast
Treatment for cerebral small v ...... arterioles during hypertension
@en
P2860
P356
P1433
P1476
Treatment for cerebral small v ...... arterioles during hypertension
@en
P2093
Julie G Sweet
Marilyn J Cipolla
P2860
P304
P356
10.1096/FJ.13-230797
P407
P577
2013-06-19T00:00:00Z